Page 4 - Olid News Today

Zoey started out as a NICU baby who was not able to move or eat on her own.

PENDLETON, Ore.-Oregon State Police will be increasing patrols during the Pendleton Round-Up in an effort to keep travelers safe over the busy weekend.

This article was originally published on .cult by Yasas Sri Wickramasinghe. .cult is a Berlin-based community platform for developers. We write about all things

Partners Group Key word Half Year Results Partners Group reports revenue growth of 19% supported by solid performance fee development 05Sep2023 0700 CETCEST Release of an ad hoc announcement pursuant

Edisun Power Europe AG Key word Half Year Results Edisun Power Europe AG Solid performance despite headwinds 31Aug2023 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer

Zug Estates Holding AG Key word Half Year ResultsReal Estate Solid operating results in a challenging market environment 25Aug2023 0630 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR

EQSAdhoc Majorel Group Luxembourg SA Key word Half Year ResultsHalf Year Results Majorel Group Luxembourg SA Majorel delivers solid results for H1 2023 24Aug2023 0800 CETCEST Disclosure of an inside

PSP Swiss Property AG Key word Half Year Results PSP Swiss Property achieved a solid operating result Improved ebitda guidance for FY 2023 18Aug2023 0630 CETCEST Release of an ad hoc announcement pur

Gurit Holding AG Key word Half Year ResultsInterim Report Gurit reports solid net sales of CHF 2446 million in the first half of 2023 and an improved profitability 16Aug2023 0650 CETCEST Release of a

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies Astellas to invest a total of $50 million to acquire approximately 8.8% of Poseida and to receive a right of exclusive negotiation and first refusal for any potential partnering of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy product candidate for solid tumors Astellas will have the right to designate an obser...